Abstract:The identification of drug-target interactions (DTIs) is a critical step in drug development. Experimental methods that are based on clinical trials to discover DTIs are time-consuming, expensive, and challenging. Therefore, as complementary to it, developing new computational methods for predicting novel DTI is of great significance with regards to saving cost and shortening the development period. In this paper, we present a novel computational model for predicting DTIs, which uses the sequence information of proteins and a rotation forest classifier. Specifically, all of the target protein sequences are first converted to a position-specific scoring matrix (PSSM) to retain evolutionary information. We then use local phase quantization (LPQ) descriptors to extract evolutionary information in the PSSM. On the other hand, substructure fingerprint information is utilized to extract the features of the drug. We finally combine the features of drugs and protein together to represent features of each drug-target pair and use a rotation forest classifier to calculate the scores of interaction possibility, for a global DTI prediction. The experimental results indicate that the proposed model is effective, achieving average accuracies of 89.15%, 86.01%, 82.20%, and 71.67% on four datasets (i.e., enzyme, ion channel, G protein-coupled receptors (GPCR), and nuclear receptor), respectively. In addition, we compared the prediction performance of the rotation forest classifier with another popular classifier, support vector machine, on the same dataset. Several types of methods previously proposed are also implemented on the same datasets for performance comparison. The comparison results demonstrate the superiority of the proposed method to the others. We anticipate that the proposed method can be used as an effective tool for predicting drug-target interactions on a large scale, given the information of protein sequences and drug fingerprints.

Multi-algorithm and Multi-Model Based Drug Target Prediction and Web Server

TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

Accurate Prediction of Potential Druggable Proteins Based on Genetic Algorithm and Bagging-SVM Ensemble Classifier

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Prediction of Potential Drug Targets Based on Simple Sequence Properties

A Computational Approach For Predicting Drug-Target Interactions From Protein Sequence And Drug Substructure Fingerprint Information

Drug-Target Interaction Prediction Based On Drug Fingerprint Information And Protein Sequence

Analysis of protein features and machine learning algorithms for prediction of druggable proteins

CODD-Pred: A Web Server for Efficient Target Identification and Bioactivity Prediction of Small Molecules

Efficient Data Mining Algorithms for Screening Potential Proteins of Drug Target

Predicting Mtor Inhibitors with a Classifier Using Recursive Partitioning and Naïve Bayesian Approaches.

D3CARP: a comprehensive platform with multiple-conformation based docking, ligand similarity search and deep learning approaches for target prediction and virtual screening

A Systematic Prediction of Drug-Target Interactions Using Molecular Fingerprints and Protein Sequences

Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.

NetInfer: A Web Server for Prediction of Targets, Therapeutic and Adverse Effects via Network-Based Inference Methods.

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences